Home 5 Articles 5 FDA Clears the Way for Serial Use At-Home and Point-of-Care Asymptomatic Screening Tests

FDA Clears the Way for Serial Use At-Home and Point-of-Care Asymptomatic Screening Tests

by | Mar 23, 2021

At-home and point-of-care (POC) serial testing for purposes of screening the asymptomatic is, arguably, the most promising, long-term market for new SARS-CoV-2 diagnostics. On March 16, 2021, the U.S. Food and Drug Administration (FDA) issued new guidance to help developers of these tests bring their products to market faster. Here is a rundown of the […]

This content is exclusive to Diagnostic Testing and Emerging Technologies subscribers

Start a Free Trial for immediate access to this article and our entire archive of over 20 years of DTET reports.